Healthcare utilization among children with a history of neonatal opioid withdrawal syndrome: A matched cohort study
- PMID: 36302288
- DOI: 10.1016/j.chiabu.2022.105934
Healthcare utilization among children with a history of neonatal opioid withdrawal syndrome: A matched cohort study
Abstract
Objectives: Compare longitudinal healthcare utilization patterns in children with and without a history of neonatal opioid withdrawal syndrome (NOWS).
Study design: A retrospective matched cohort study was conducted using billing data extracted from between 2003 and 2016 in North Texas hospitals. The sample included 595 pediatric patients diagnosed with NOWS (i.e. exposed). The unexposed were patients not diagnosed with NOWS and matched 4:1 on sex, age at first encounter, and ethnicity to the exposed who received care during the same period. Multi-level regression models (accounting for clustered data structure of multiple visits per patient) compared number of hospitalizations, number of outpatient visits, number of emergency department (ED) visits, average length of stay, and healthcare expenditures across patients with and without NOWS.
Results: Hospitalizations were significantly lower among exposed (Incidence Rate Ratio [IRR] = 0.58, 95 % Confidence Interval [CI] = 0.44-0.77) compared to unexposed. Outpatient visits, ED visits, and average length of stay was significantly higher among exposed compared to unexposed (IRR = 1.19, 95 % CI = 1.04-1.36; IRR = 1.22, 95 % CI = 1.04-1.42; IRR = 2.21, 95 % CI = 2.03-2.42, respectively). Overall healthcare expenditure was greater among exposed, as well as for patients with neurologic, endocrine, cardiac, mental disorders, respiratory, perinatal, infectious disease, eye, ear, digestive, congenital anomaly, and skin diagnoses.
Conclusions: Children with a diagnosis of NOWS have significantly higher healthcare expenditures, and with the exception of hospitalizations, higher healthcare utilization beyond the newborn visit. These findings suggest the needs for interventions for children with NOWS beyond the immediate neonatal period.
Keywords: Longitudinal healthcare utilization; Neonatal Opioid Withdrawal Syndrome; Pediatrics.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest None to report.
Similar articles
-
Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome.Neurotoxicol Teratol. 2021 Jul-Aug;86:106975. doi: 10.1016/j.ntt.2021.106975. Epub 2021 Mar 23. Neurotoxicol Teratol. 2021. PMID: 33766722 Free PMC article.
-
Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.JAMA Netw Open. 2022 Aug 1;5(8):e2228588. doi: 10.1001/jamanetworkopen.2022.28588. JAMA Netw Open. 2022. PMID: 36001312 Free PMC article.
-
Maternal opioid use during pregnancy and the risk of neonatal opioid withdrawal syndrome in the offspring.Acta Obstet Gynecol Scand. 2024 Aug;103(8):1522-1529. doi: 10.1111/aogs.14850. Epub 2024 May 3. Acta Obstet Gynecol Scand. 2024. PMID: 38700023 Free PMC article.
-
Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A Review.CNS Drugs. 2019 Nov;33(11):1113-1120. doi: 10.1007/s40263-019-00681-9. CNS Drugs. 2019. PMID: 31686408 Review.
-
Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach.Neurotoxicol Teratol. 2021 Nov-Dec;88:107020. doi: 10.1016/j.ntt.2021.107020. Epub 2021 Aug 19. Neurotoxicol Teratol. 2021. PMID: 34419619 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources